tiprankstipranks
Trending News
More News >
Kontafarma China Holdings Ltd (HK:1312)
:1312
Hong Kong Market
Advertisement

Kontafarma China Holdings Ltd (1312) Financial Statements

Compare
0 Followers

Kontafarma China Holdings Ltd Financial Overview

Kontafarma China Holdings Ltd's market cap is currently HK$172.94M. The company's EPS TTM is HK$-0.014; its P/E ratio is ―; Kontafarma China Holdings Ltd is scheduled to report earnings on March 28, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueHK$ 897.52MHK$ 809.11MHK$ 894.06MHK$ 961.09MHK$ 1.01B
Gross ProfitHK$ 516.16MHK$ 471.29MHK$ 506.22MHK$ 482.89MHK$ 555.75M
Operating IncomeHK$ -42.51MHK$ 0.00HK$ -47.06MHK$ -42.56MHK$ 40.39M
EBITDAHK$ -49.93MHK$ 76.63MHK$ 26.93MHK$ 112.18MHK$ 156.31M
Net IncomeHK$ -75.54MHK$ -28.84MHK$ -109.74MHK$ -4.55MHK$ -20.09M
Balance Sheet
Cash & Short-Term InvestmentsHK$ 90.58MHK$ 87.66MHK$ 142.59MHK$ 183.96MHK$ 194.79M
Total AssetsHK$ 1.59BHK$ 1.73BHK$ 2.12BHK$ 2.56BHK$ 2.54B
Total DebtHK$ 297.19MHK$ 333.82MHK$ 590.72MHK$ 728.95MHK$ 751.29M
Net DebtHK$ 216.60MHK$ 256.16MHK$ 468.13MHK$ 560.99MHK$ 585.48M
Total LiabilitiesHK$ 625.90MHK$ 665.39MHK$ 964.16MHK$ 1.22BHK$ 1.19B
Stockholders' EquityHK$ 978.70MHK$ 1.06BHK$ 1.10BHK$ 1.19BHK$ 1.21B
Cash Flow
Free Cash FlowHK$ 33.41MHK$ 12.92MHK$ -53.84MHK$ -49.31MHK$ 51.02M
Operating Cash FlowHK$ 47.05MHK$ 37.12MHK$ -2.17MHK$ 75.07MHK$ 206.93M
Investing Cash FlowHK$ -6.01MHK$ 144.14MHK$ 121.53MHK$ 23.24MHK$ -206.12M
Financing Cash FlowHK$ -42.52MHK$ -198.81MHK$ -137.33MHK$ -99.80MHK$ 19.10M
Currency in HKD

Kontafarma China Holdings Ltd Earnings and Revenue History

Kontafarma China Holdings Ltd Debt to Assets

Kontafarma China Holdings Ltd Cash Flow

Kontafarma China Holdings Ltd Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis